Ginsenoside Rs3

CAS No. 194861-70-6

Ginsenoside Rs3( ——— )

Catalog No. M38941 CAS No. 194861-70-6

Ginsenoside Rs3 is a natural diol-type ginseng saponin with anticancer effects. Ginsenoside Rs3 selectively elevates protein levels of p53 and p21WAF1 leading to induction of apoptosis in SK-HEP-1 cells.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 487 Get Quote
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Ginsenoside Rs3
  • Note
    Research use only, not for human use.
  • Brief Description
    Ginsenoside Rs3 is a natural diol-type ginseng saponin with anticancer effects. Ginsenoside Rs3 selectively elevates protein levels of p53 and p21WAF1 leading to induction of apoptosis in SK-HEP-1 cells.
  • Description
    Ginsenoside Rs3 induce apoptosis, is related to the elevations of p53 and p21WAF1 in the cells.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Apoptosis
  • Target
    p53
  • Recptor
    p53
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    194861-70-6
  • Formula Weight
    827.062
  • Molecular Formula
    C44H74O14
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. S E Kim, et al. Ginsenoside-Rs3, a new diol-type ginseng saponin, selectively elevates protein levels of p53 and p21WAF1 leading to induction of apoptosis in SK-HEP-1 cells. Anticancer Res. 1999 Jan-Feb;19(1A):487-91.?
molnova catalog
related products
  • DPBQ

    DPBQ is a factor that activates p53.

  • Amifostine thiol dih...

    WR-1065 dihydrochloride can activate p53 through a JNK-dependent signaling pathway. It also protects normal tissues from the toxic effects of certain cancer drugs.

  • (-)-Curine

    (-)-Curine can inhibit viability of hepatocellular carcinoma cells in regardless of p53 status.